T. Zumarraga Lizundia
YOU?
Author Swipe
View article: 61eP PI3K pathway inhibition in endometrial cancer: A single center experience
61eP PI3K pathway inhibition in endometrial cancer: A single center experience Open
View article: 103P Real-world tumor-based next-generation sequencing in ovarian cancer: Descriptive analysis
103P Real-world tumor-based next-generation sequencing in ovarian cancer: Descriptive analysis Open
View article: Neoadjuvant Statistical Algorithm to Predict Individual Risk of Relapse in Patients with Resected Liver Metastases from Colorectal Cancer
Neoadjuvant Statistical Algorithm to Predict Individual Risk of Relapse in Patients with Resected Liver Metastases from Colorectal Cancer Open
(1) Background: Liver metastases (LM) are the leading cause of death in colorectal cancer (CRC) patients. Despite advancements, relapse rates remain high and current prognostic nomograms lack accuracy. Our objective is to develop an interp…
View article: 28O Comparison of prognostic scores in oncology patients participating in phase I clinical trials with immunotherapy
28O Comparison of prognostic scores in oncology patients participating in phase I clinical trials with immunotherapy Open
Phase I studies are designed to evaluate the toxicity and maximum tolerated dose of a new drug but, for the last decade, antitumoral activity is also measured in this type of trials. Usually, an expected overall survival of at least three …
View article: Predicting Severe Haematological Toxicity in Gastrointestinal Cancer Patients Undergoing 5-FU-Based Chemotherapy: A Bayesian Network Approach
Predicting Severe Haematological Toxicity in Gastrointestinal Cancer Patients Undergoing 5-FU-Based Chemotherapy: A Bayesian Network Approach Open
Purpose: Severe toxicity is reported in about 30% of gastrointestinal cancer patients receiving 5-Fluorouracil (5-FU)-based chemotherapy. To date, limited tools exist to identify at risk patients in this setting. The objective of this stud…